Loading clinical trials...
Loading clinical trials...
Value of TFF3, SFRP4, Romo1 and NFKB as Serum Biomarkers in Diagnosis and Predicting Prognosis of Ovarian Cancers
Conditions
Interventions
TFF3, SFRP4, Romo1, NFKB
Locations
1
Turkey (Türkiye)
Istanbul University Cerrahpasa Medical Faculty
Istanbul, Turkey (Türkiye)
Start Date
April 4, 2017
Primary Completion Date
June 21, 2018
Completion Date
May 30, 2019
Last Updated
February 26, 2019
NCT07213804
NCT07046923
NCT06051695
NCT06885697
NCT05129969
NCT05770102
Lead Sponsor
Ilker Kahramanoglu
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions